Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord

Annals of Thoracic Surgery

Volumn 72, Issue 4, 2001, Pages 1245-1250

  Cassada, David C ^a   Gangemi, James J ^a   Rieger, Jayson M ^a   Linden, Joel ^a   Kaza, Aditya K ^a   Long, Stewart M ^a   Kron, Irving L ^a   Tribble, Curtis G ^a   Kern, John A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [6 AMINO 9 (5 ETHYLCARBAMOYL 3,4 DIHYDROXYTETRAHYDRO 2 FURYL) 9H PURIN 2 YL] 2 PROPYNYL]CYCLOHEXANECARBOXYLIC ACID METHYL ESTER; ADENOSINE A2A RECEPTOR AGONIST; ANTIBODY; SMI33 ANTIBODY; UNCLASSIFIED DRUG; ADENOSINE A2A RECEPTOR; ADENOSINE RECEPTOR; CYCLOHEXANECARBOXYLIC ACID DERIVATIVE; PURINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; DRUG TOLERABILITY; FOLLOW UP; HEMODYNAMICS; HINDLIMB; IMMUNOHISTOCHEMISTRY; LUMBAR SPINAL CORD; NEUROFILAMENT; NONHUMAN; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RABBIT; REPERFUSION INJURY; SPINAL CORD INJURY; SPINAL CORD ISCHEMIA; SPINAL CORD VENTRAL HORN; TREATMENT OUTCOME; ANIMAL; CELL SURVIVAL; DRUG EFFECT; DRUG POTENTIATION; NERVE CELL; NEUROLOGIC EXAMINATION; PATHOLOGY; SPINAL CORD;

ANIMALS; CELL SURVIVAL; CYCLOHEXANECARBOXYLIC ACIDS; NEUROLOGIC EXAMINATION; NEURONS; PURINES; RABBITS; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; REPERFUSION INJURY; SPINAL CORD; SPINAL CORD ISCHEMIA;

EID: 0034740746     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(01)03057-0     Document Type: Article

References (27)

1. Evolving experience with thoracoabdominal aortic aneurysm repair at a single institution
2. Experience with 1509 patients undergoing thoracoabdominal aortic operations
3. Surgical experience in descending thoracic aneurysmectomy with and without adjuncts to avoid ischemia
4. Thoracoabdominal aneurysm repair: A representative experience
5. Thoracoabdominal aortic aneurysms: Preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients
6. Prevention of ischemic spinal cord injury after aortic cross-clamping: Use of corticosteroids
7. Neuronal cell death in the ischemic spinal cord: The effect of methylprednisolone
8. Hypothermic retrograde venous perfusion with adenosine cools the spinal cord and reduces the risk of paraplegia after thoracic aortic clamping
9. Reducing postischemic paraplegia using conjugated superoxide dismutase
10. Clamp and sew techniques in thoracoabdominal aortic surgery using naloxone and CSF drainage
11. Adenosine agonist reduces spinal cord reperfusion injury in a time dependent fashion
12. Preservation of intercostal arteries during thoracoabdominal aortic aneurysm surgery: A retrospective study
13. Moderate hypothermia, with partial bypass and segmental sequential repair for thoracoabdominal aortic aneurysm
14. Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine
15. Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model
16. The adenosine/neutrophil paradox resolved: Human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively
17. Spinal cord protection during aortic cross-clamping using retrograde venous perfusion
18. Design, synthesis, and evaluation of novel A2A adenosine receptor agonists
19. Role of A2A adenosine receptors in inflammation
20. Changes in cerebrospinal fluid pressure and spinal cord perfusion pressure before cross-clamping of the thoracic aorta in humans
21. Molecular cloning and characterization of a rat A1-adenosine receptor that is widely expressed in brain and spinal cord
22. A physiological role of the adenosine A3 receptor: Sustained cardioprotection
23. Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence
24. Propentofylline enhancement of the actions of adenosine on neutrophil leukocytes
25. The role of inflammation in vascular diseases
26. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells
27. Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes